Detalhe da pesquisa
1.
MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells.
Proc Natl Acad Sci U S A
; 110(25): 10258-63, 2013 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23733953
2.
Hsa-miR-323a-3p functions as a tumor suppressor and targets STAT3 in neuroblastoma cells.
Front Pediatr
; 11: 1098999, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37033189
3.
Molecular modelling of the GIR1 branching ribozyme gives new insight into evolution of structurally related ribozymes.
EMBO J
; 27(4): 667-78, 2008 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18219270
4.
Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
Differentiation
; 81(1): 25-34, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20980091
5.
MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma.
Carcinogenesis
; 32(7): 1005-12, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21572098
6.
Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma.
BMC Dev Biol
; 11: 1, 2011 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21194500
7.
A conformational switch in the DiGIR1 ribozyme involved in release and folding of the downstream I-DirI mRNA.
RNA
; 15(5): 958-67, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19329537
8.
Comparison of RNAi efficiency mediated by tetracycline-responsive H1 and U6 promoter variants in mammalian cell lines.
Nucleic Acids Res
; 35(9): e67, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17426119
9.
Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma.
Cancer Inform
; 18: 1176935119832910, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30886518
10.
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma.
Oncogene
; 38(15): 2800-2813, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30542116
11.
Hsa-miR-376c-3p targets Cyclin D1 and induces G1-cell cycle arrest in neuroblastoma cells.
Oncol Lett
; 16(5): 6786-6794, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30405823
12.
MicroRNA-193b-3p represses neuroblastoma cell growth via downregulation of Cyclin D1, MCL-1 and MYCN.
Oncotarget
; 9(26): 18160-18179, 2018 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29719597
13.
Short-term sequence evolution and vertical inheritance of the Naegleria twin-ribozyme group I intron.
BMC Evol Biol
; 6: 39, 2006 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-16670006
14.
RNA reprogramming of alpha-mannosidase mRNA sequences in vitro by myxomycete group IC1 and IE ribozymes.
FEBS J
; 273(12): 2789-800, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16817905
15.
Editorial: Molecular Mechanisms and Treatment of MYCN-Driven Tumors.
Front Oncol
; 11: 803443, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34917517
16.
Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment.
Cancer Lett
; 372(1): 128-36, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26708804
17.
Exosome-like Extracellular Vesicles from MYCN-amplified Neuroblastoma Cells Contain Oncogenic miRNAs.
Anticancer Res
; 35(5): 2521-30, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25964525
18.
Wnt/ß-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
Nat Commun
; 6: 8904, 2015 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26603103
19.
DiGIR1 and NaGIR1: naturally occurring group I-like ribozymes with unique core organization and evolved biological role.
Biochimie
; 84(9): 905-12, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12458083
20.
Optimization and application of the group I ribozyme trans-splicing reaction.
Methods Mol Biol
; 252: 359-71, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15017063